Effect of white matter lesions on brain perfusion in alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 34, Issue 3-4, 2012, Pages 256-261

  Kimura, Noriyuki ^a   Nakama, Hiroshi ^a   Nakamura, Kenichirou ^a   Aso, Yasuhiro ^a   Kumamoto, Toshihide ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Brain single photon emission computed tomography; Cerebral blood flow; Magnetic resonance imaging; Statistical Parametric Mapping 8; White matter lesions

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CYSTEINE ETHYL ESTER TC 99M; HYPOCHOLESTEROLEMIC AGENT;

AGED; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ANTERIOR INSULA; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOXEL BASED MORPHOMETRY; WHITE MATTER LESION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84869883686     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000345184     Document Type: Article

References (32)

1. Brun A, Englund E: A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19:253-262.
2. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
3. DeCarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA, Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI, et al: The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-2084.
4. Mineura K, Sasajima H, Kikuchi K, Kowada M, Tomura N, Monma K, Segawa Y: White matter hyperintensity in neurologically asymptomatic subjects. Acta Neurol Scand 1995;92:151-156.
5. Amar K, Bucks RS, Lewis T, Scott M, Wilcock GK: The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type. Age Ageing 1996;25:443-448.
6. Blennow K, Wallin A, Uhlemann C, Gottfries CG: White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand 1991;83:187-193.
7. Leys D, Pruvo JP, Parent M, Vermersch P, Soetaert G, Steinling M, Delacourte A, Defossez A, Rapoport A, Clarisse J, et al: Could Wallerian degeneration contribute to 'leukoaraiosis' in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 1991; 54:46-50.
8. Marder K, Richards M, Bello J, Bell K, Sano M, Miller L, Folstein M, Albert M, Stern Y: Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Arch Neurol 1995;52:146-151.
9. Kozachuk WE, DeCarli C, Schapiro MB, Wagner EE, Rapoport SI, Horwitz B: White matter hyperintensities in dementia of Alzheimer's type and in healthy subjects without cerebrovascular risk factors. A magnetic resonance imaging study. Arch Neurol 1990; 47:1306-1310.
10. Almkvist O, Wahlund LO, Andersson-Lundman G, Basun H, Backman L: White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49:626-632.
11. Heo JH, Lee ST, Kon Chu, Park HJ, Shim JY, Kim M: White matter hyperintensities and cognitive dysfunction in Alzheimer disease. J Geriatr Psychiatry Neurol 2009;22:207-212.
12. Vidar Stenset V, Dag Hofoss D, Audun Elnaes Berstad AE, Anne Negaard A, Leif Gjerstad L, Fladbya T: White matter lesion subtypes and cognitive deficits in patients with memory impairment. Dement Geriatr Cogn Disord 2008;26:424-431.
13. Kimura N, Hanaki S, Masuda T, Hanaoka T, Hazama Y, Okazaki T, Arakawa R, Kumamoto T: Brain perfusion differences in Parkinsonian disorders. Mov Disord 2011;26: 2530-2537.
14. Levy-Cooperman N, Lobaugh NJ, Caldwell C, Gao F, Black SE: Subcortical hyperintensities in Alzheimer's disease: no clear relationship with executive function and frontal perfusion on SPECT. Dement Geriatr Cogn Disord 2007;24:380-388.
15. Ott BR, Faberman RS, Noto RB, Rogg JM, Hough TJ, Tung GA, Spencer PK: A SPECT imaging study of MRI white matter hyperintensity in patients with degenerative dementia. Dement Geriatr Cogn Disord 1997;8:348-354.
16. Siennicki-Lantz A, Lilja B, Rosen I, Elmstahl S: Cerebral blood flow in white matter is correlated with systolic blood pressure and EEG in senile dementia of the Alzheimer type. Dement Geriatr Cogn Disord 1998;9:29-38.
17. Waldemar G, Christiansen P, Larsson HB, Hogh P, Laursen H, Lassen NA, Paulson OB: White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. J Neurol Neurosurg Psychiatry 1994;57:1458-1465.
18. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
19. Molgaard CA: Multivariate analysis of Hachinski's Scale for discriminating senile dementia of the Alzheimer's Type from multiinfarct dementia. Neuroepidemiology 1987;6: 153-160.
20. Matsuda H, Tsuji S, Shuke N, et al: Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1993;20:391-401.
21. Leys D, Soetaert G, Petit H, Fauquette A, Pruvo JP, Steinling M: Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol 1990;47:524-527.
22. Harrell LE, Duvall E, Folks DG, Duke L, Bartolucci A, Conboy T, Callaway R, Kerns D: The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease. Arch Neurol 1991;48:1136-1140.
23. Kertesz A, Polk M, Carr T: Cognition and white matter changes on magnetic resonance imaging in dementia. Arch Neurol 1990;47: 387-391.
24. Shelley BP, Trimble MR: The insular lobe of Reil-Its anatamico- functional, behavioural and neuropsychiatric attributes in humans-A review. World J Biol Psychiatry 2004;5: 176-200.
25. Feinstein JS, Rudrauf D, Khalsa SS, et al: Bilateral limbic system destruction in man. J Clin Exp Neuropsychol 2009;7:1-19.
26. Cummings JL: Subcortical dementia: neuropsychology, neuropsychiatry and pathophysiology. Br J Psychiatry 1986;149:682-697.
27. Bracco L, Piccini C, Moretti M, Mascalchi M, Sforza A, Nacmias B, Cellini E, Bagnoli S, Sorbi S: Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. Dement Geriatr Cogn Disord 2005;20:358-366.
28. DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, Rapoport SI: Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J Neurol Neurosurg Psychiatry 1996;60:158-167.
29. Kobari M, Meyer JS, Ichijo M, Oravez WT: Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol 1999;11:273-281.
30. Kawamura J, Meyer JS, Ichijo M, Kobari M, Terayama Y, Weathers S: Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. J Neurol Neurosurg Psychiatry 1993;56:182-187.
31. De Reuck J, Decoo D, Strijckmans K, Lemahieu I: Does the severity of leukoaraiosis contribute to senile dementia? A comparative computerized and positron emission tomographic study. Eur Neurol 1992;32:199-205.
32. Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H, Sakurai H, Iwamoto T: Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. J Neurol 2011;258:1295-1303.